{"name":"IDP Discovery Pharma S.L.","slug":"idp-discovery-pharma-s-l","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPSGhnWkIwbTRiS1BnbmdtSFhqR0QzbU4xUFQ4bnpQekdjMWdXVW1xYXVja214b2JXOGNCNV9VYVBJRDEyS0pzaGtfekxXRzZyd1M2bXpnclRMdzFYWUZvODVJSzJXcHJJUzNXRFo3ODhOQmhRc2hiMktKTDNFVjFfdUszaE8wdWFwMThDOUsxeUFyZU1XMi1Xb0dRTVFnRV9IcExRWUc5R1BZTDZjNFpObkE1TnFzdWdOQkxWcXFWSVQzLXFqNVlqMUNsUWlnUVlkOTQtU1dOUGlrN25vSXd2LUEyZDNuSGxSQVd4ZEhoRTdDM28tRmdXdzl5eHhDaG50Tzl0TWZJdW0?oc=5","date":"2025-08-27","type":"pipeline","source":"PR Newswire","summary":"Diffuse Large B-cell Lymphoma Market to Grow at a CAGR of 13% by 2034 in Leading Markets (US, EU4, UK, and Japan) | DelveInsight - PR Newswire","headline":"Diffuse Large B-cell Lymphoma Market to Grow at a CAGR of 13% by 2034 in Leading Markets (US, EU4, UK, and Japan) | Delv","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxPRVd6WXpfckdJZGoxTUJaOGRyaXpqcXgzX1RSS0xmRFp6MEx5NUJqQkZfaW5rQTRSMDBJWG9mZ2ZnQUMtZl9WTkhoNFdiZ1hyekYxUXczTzhhZlZtd1ZsSWg0d2plTnZPU3pUY0xsR0g0MnQ2OGUtcXdzOExuaEhJdDNoMGRLZ0owUzZ0WHFweHZRZnlrODBud0htTzUwcndEb1A2QzdQb3dOTFBMSGM3MmJCZEVmZmthNmdibmN6MnBNYmtFLTdNSzl3X2FZSmUyN3lNemFaQ1JmNnI2dU9ZLWVMSFgyQXlzU0thSGl3ZWpDbklKbjlpelA4WEFhQTlxMzIyYlB3cHRGNWhDRnVmb0Z0NlVOSnFSU3B0Zzh0eFgtbWlGTEtlMURhNjFUd3dFMEow?oc=5","date":"2025-07-21","type":"pipeline","source":"globenewswire.com","summary":"Cutaneous T-cell Lymphoma Market Anticipates Impressive - globenewswire.com","headline":"Cutaneous T-cell Lymphoma Market Anticipates Impressive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOMkUxaG9BOFRRaFIzbXJEc2pmc2d0TE5ybE9yNDJUaGZ3NVo5OE45aDlQX0phZWdManVGc05aSzFVQ1FGQ2txdW9mdEUyYjhDZEliZmVXaEFJcUxBd0ZWWXg5VTgxMGN0N1VXdll6Wm10Qk03dEM2Zl9BNlZLSndDd210ZlZnLWJPOVg0N2NnbHF0bGU0V0FIRHhDRmJEZDY1Q0s3aWc4S3Izbm9zeUpWSGVrc0FITllJRHk4cG5pWWFYc3J5ZXpOSFhUTjI4Tms5NXRfN045MA?oc=5","date":"2025-03-11","type":"pipeline","source":"PR Newswire","summary":"BREYANZI Demonstrates Continued Growth in the Competitive CAR-T Market | DelveInsight - PR Newswire","headline":"BREYANZI Demonstrates Continued Growth in the Competitive CAR-T Market | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNcThTYnBTaFZXUXdNYzlhY0ZBdUlXNzE4cnVhSzlCVFF1T0JEeG9odldXSWtaYkQ4UmlCbzJrVVFsVWZMc0x5d1UxZkRXeUhsNTNnYkUySHNOOTZGZzVCYkNhMlBPRm1rUWpVNU9VUGhuRTlQQms4TnlpVnJEd0QyeENydmtnZkRNdmNDT0FIN3dvMVJ5SXNfS1pTTnBFWW53Y0RTazN6a2tQRXQ4ZnQwN0luYm9HTkxydE1EVVpWeS0zam9NRXp1UHlETlBkUWxYUmJIcTRvQkpyQVRLVjdIVWlqZ2U2dUtYbXVqUnhXamZVWlVSM25jT0tjX1Y0SC13dWNB?oc=5","date":"2025-03-05","type":"pipeline","source":"PR Newswire","summary":"XPOVIO Continues to Disrupt the Oncology Market with Expanded Indications and Strong Market Performance | DelveInsight - PR Newswire","headline":"XPOVIO Continues to Disrupt the Oncology Market with Expanded Indications and Strong Market Performance | DelveInsight","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}